Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Rayca Precision

Pioneering AI-Enabled Solutions for Precision Medicine and Drug Discovery Research
2022
Nov-50
11-50
London, England, United Kingdom
  • Drug Discovery and Development
  • Pathology & Diagnostics
  • Personalized Medicine Technologies
  • Services (Patient care)
  • Telemedicine

Innovation

Industry Problem

Drug discovery is slow, expensive, and prone to failure because promising targets and responsive patient groups are difficult to identify early.

R&D Focus

AI-assisted target discovery and drug development

Innovative Solution

Our platform features automated downstream pipelines that leverage machine learning for various critical applications, including Biomarker and Target Discovery, Genotype-Phenotype Prediction, Prognosis Modeling, Cohort Stratification and Optimization, and Treatment Response Prediction Modeling. These pipelines enhance our ability to deliver precise and predictive insights across different stages of patient care and drug development.

Investment Funding

Revenue

$1M to $10M

People

Founders

About

Rayca Precision is at the forefront of transforming precision healthcare through our advanced bioinformatics and machine learning technologies. Our signature innovation, the Secure Research Environment (SRE), ensures data integrity and confidentiality, facilitating secure data sharing without the data ever leaving its original location. This capability breaks down traditional data silos, maximizing the utility and security of healthcare data while adhering to strict privacy regulations. Our platform features automated downstream pipelines that leverage machine learning for various critical applications, including Biomarker and Target Discovery, Genotype-Phenotype Prediction, Prognosis Modeling, Cohort Stratification and Optimization, and Treatment Response Prediction Modeling. These pipelines enhance our ability to deliver precise and predictive insights across different stages of patient care and drug development.

Products

Product

Our platform features automated downstream pipelines that leverage machine learning for various critical applications, including Biomarker and Target Discovery, Genotype-Phenotype Prediction, Prognosis Modeling, Cohort Stratification and Optimization, and Treatment Response Prediction Modeling.

Something missing or incorrect on this page? Help us enrich this information